21 completed. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 21 |
Follow Diabetic Nephropathy: new trials by email Literature Review of Diabetic Nephropathy trials Research Report on Diabetic Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. Ertugliflozin 15 mg - Type 2 Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Completed | Amsterdam UMC, location VUmc | 40 | 2020-12-10 | 2023-05-01 |
| Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes sodium bicarbonate - Type 1 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | University of Colorado, Denver | 45 | 2017-01-01 | 2026-06-17 |
| CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea Continuous positive airway pressure, Pharmacological treatment, Diet - Diabetic Nephropathy, Sleep Apnea | Phase 4 | Completed | Hospital Universitario La Paz | 180 | 2016-06-01 | 2021-05-11 |
| Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy Lipo-PGE1 - Diabetic Nephropathy | Phase 4 | Completed | West China Hospital | 21 | 2015-12-01 | 2016-12-29 |
| Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes Dapagliflozine 10 mg once daily tablet treatment, Placebo identical once daily tablet treatment - Type 2 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | Peter Rossing | 40 | 2015-08-01 | 2018-09-10 |
| Microalbuminuria and Allopurinol in Type 1 Diabetes Allopurinol, Placebo - Type 1 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | Peter Rossing | 30 | 2014-09-01 | 2018-09-10 |
| Effect of LIXIsenatide on the Renal System Lixisenatide, Insulin glulisine - Diabetic Kidney Disease, Diabetic Nephropathy | Phase 4 | Completed | Amsterdam UMC, location VUmc | 40 | 2014-09-01 | 2016-04-29 |
| Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) Anplag(Sarpogrelate), Placebo - Diabetic Nephropathy | Phase 4 | Completed | Yuhan Corporation | 151 | 2013-02-01 | 2021-04-23 |
| Renal Denervation in Diabetic Nephropathy Percutaneous renal denervation and TMNS, Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin - Diabetic Nephropathy, Persistent Proteinuria With Type II Diabetes | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 25 | 2012-04-01 | 2016-06-01 |
| Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy Paricalcitol - Cardiovascular Disease, Diabetic Nephropathy | Phase 4 | Completed | Peter Rossing | 48 | 2010-04-01 | 2012-04-13 |
| A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy Probucol, Probucol and Cilostazol - Diabetic Nephropathy | Phase 4 | Completed | Otsuka Beijing Research Institute | 353 | 2010-03-01 | 2013-05-08 |
| Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) ACTH - Diabetic Nephropathy, Nephrotic Syndrome | Phase 4 | Completed | Southeast Renal Research Institute | 15 | 2009-05-01 | 2013-05-31 |
| Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria ramipril - Proteinuria, Diabetic Nephropathy | Phase 4 | Completed | Gulhane School of Medicine | 78 | 2008-01-01 | 2009-06-03 |
| FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients Ramipril - Proteinuria, Diabetic Nephropathy | Phase 4 | Completed | Gulhane School of Medicine | 78 | 2008-01-01 | 2012-10-10 |
| Benfotiamine in Diabetic Nephropathy Benfotiamine, Placebo - Diabetic Nephropathy | Phase 4 | Completed | University Medical Center Groningen | 86 | 2007-12-01 | 2009-11-16 |
| Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) Ketosteril®, diabetic diet - Diabetic Nephropathy | Phase 4 | Completed | Fresenius Kabi | 179 | 2006-05-01 | 2010-09-02 |
| Nephropathy In Type 2 Diabetes and Cardio-renal Events SoC therapy, irbesartan, ramipril - Diabetic Nephropathy | Phase 4 | Completed | University of Campania Luigi Vanvitelli | 850 | 2005-10-01 | 2020-08-03 |
| Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Cyclosporin, Tacrolimus, 'Diabetes Education / Management' - Kidney Transplant, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Stanford University | 29 | 2005-06-01 | 2017-10-06 |
| Antiproteinuric Effect of Valsartan and Lisinopril Valsartan, Valsartan plus HCTZ, Lisinopril - Hypertension, Diabetic Nephropathy | Phase 4 | Completed | Novartis | 124 | 2004-11-01 | 2017-02-24 |
| Spironolactone in Diabetic Nephropathy Spironolactone - Diabetic Nephropathy | Phase 4 | Completed | Steno Diabetes Center Copenhagen | 48 | 2003-09-01 | 2006-04-25 |
Showing 20 of 21. Sign in to see all of them.
Diabetic Nephropathies (21) · Diabetes Mellitus, Type 2 (4) · Albuminuria (3) · Diabetes Mellitus (3) · Kidney Diseases (3) · Diabetes Mellitus, Type 1 (2) · Proteinuria (2) · Renal Insufficiency, Chronic (2) · Autoimmune Lymphoproliferative Syndrome, Type IA (1) · Cardiovascular Diseases (1) · Hypertension (1) · Kidney Failure, Chronic (1) · Nephrotic Syndrome (1) · Renal Insufficiency (1) · Sleep Apnea Syndromes (1)
Diabetes Complications (21) · Endocrine System Diseases (21) · Female Urogenital Diseases (21) · Female Urogenital Diseases and Pregnancy Complications (21) · Male Urogenital Diseases (21) · Urogenital Diseases (21) · Urologic Diseases (21) · Diabetes Mellitus (18) · Kidney Diseases (18) · Glucose Metabolism Disorders (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (5) · Urination Disorders (5)
Ramipril (3) · Hydrochlorothiazide (2) · Lisinopril (2) · Adrenocorticotropic Hormone (1) · Allopurinol (1) · Alprostadil (1) · Amlodipine (1) · Aspirin (1) · Atenolol (1) · Cilostazol (1) · Clonidine (1) · Continuous Positive Airway Pressure (1) · Cyclosporine (1) · Diet (1) · Diet, Diabetic (1)
Peter Rossing (3) · Amsterdam UMC, location VUmc (2) · Gulhane School of Medicine (2) · Steno Diabetes Center Copenhagen (2) · Assistance Publique - Hôpitaux de Paris (1) · Fresenius Kabi (1) · Hospital Universitario La Paz (1) · Novartis (1) · Otsuka Beijing Research Institute (1) · Southeast Renal Research Institute (1) · Stanford University (1) · University Medical Center Groningen (1) · University of Campania Luigi Vanvitelli (1) · University of Colorado, Denver (1) · West China Hospital (1)
Denmark (5) · China (3) · Netherlands (3) · United States (3) · Turkey (Türkiye) (2) · France (1) · Italy (1) · South Korea (1) · Spain (1) · Switzerland (1)
D.S Choi, MD, PhD (1) · Ferdinando C Sasso, MD, PhD (1) · Francisco Garcia-Rio, MD (1) · G J Navis, MD, PhD (1) · Guillaume Bobrie, MD (1) · H JG Bilo, MD, PhD (1) · Hans-Henrik Parving, MD (1) · Hans-Henrik Parving, MD,DMSc,Prof (1) · James A. Tumlin, MD (1) · Katrine J Schjoedt, MD (1) · Lise Tarnow, MD (1) · Luca De Nicola, MD, MD (1) · Mahmut I Yilmaz, MD (1) · Peter Rossing, MD (1)
PMID 35224730, PMID 11128341, PMID 16123474, PMID 16316360, PMID 20413516, PMID 22792314, PMID 24159603, PMID 25186534, PMID 27733159, PMID 28449402, PMID 32340841, PMID 34271948, PMID 35998283, PMID 36342964, PMID 36344978, PMID 37171199, PMID 38449081, PMID 39434255
2009 (1), 2015 (1)